Alpha-2a-interferon administration and Fc gamma RIII expression on neutrophils from chronic myeloid leukemia.
Carulli
G
G
Papineschi
F
F
Azzarà
A
A
Ambrogi
F
F
D001752:Blast Crisis; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D009504:Neutrophils / Q000276:immunology*; D017452:Receptors, IgG / Q000032:analysis / Q000096:biosynthesis*; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D017452:Receptors, IgG; D011994:Recombinant Proteins; D006918:Hydroxyurea